PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy

Concurrent blockade of different checkpoint receptors, notably PD-1 and CTLA-4, elicits greater anti-tumor activity for some tumor types, and the combination of different checkpoint receptor inhibitors is an active area of clinical research. We have previously demonstrated that anti-tumor vaccinatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahm, Christopher D., Moseman, Jena E, Delmastro, Lauren E., G. Mcneel, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078506/
https://www.ncbi.nlm.nih.gov/pubmed/33996265
http://dx.doi.org/10.1080/2162402X.2021.1912892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078506/
https://www.ncbi.nlm.nih.gov/pubmed/33996265
http://dx.doi.org/10.1080/2162402X.2021.1912892

Ejemplares similares